eBay Inc. (NASDAQ:EBAY) Pay Pal is believed by RBC Capital to have the ability to grow its EBITDA at a 20.9 percent compound annual growth rate through 2020. The firm keeps an Outperform rating and raises its target to $57 from $47 on the stock.
Don’t Miss: Why is Kraft Getting KICKED Off the Dow?
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): RBC Capital believes that the FDA will approve Regeneron’s Eylea to be used in central retinal vein occlusion by September 23. According to the firm, the drug’s upcoming label and geographic expansions continues to be more positive than believed by the Street. The firm reiterates its Outperform rating on the stock.
US Physical Therapy Inc. (NASDAQ:USPH): JMP Securities continues its excitement regarding the company’s continued strength in its therapy clinic division. The firm reiterates its Outperform rating and a $29 target on the stock.
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP): ThinkEquity views the company as possessing various near-term catalysts capable of raising the stock’s value. The firm thinks that the company continues to be one of the more compelling biotech companies covered, and it has decided to keep its Buy rating on the stock.
Microsemi Corp. (NASDAQ:MSCC): Following Microsemi’s analyst day, Cantor thinks that company is continuing to increase market share in important markets as it raises revenue on existing platforms and with existing customers. The firm keeps its Buy rating and a $30 target on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>